Treating elephantiasis cuts HIV risk in Tanzania
A 12-year study in Tanzania suggests that mass drug campaigns to eliminate elephantiasis may also reduce the risk of HIV infection. Researchers are calling for these treatments to be integrated into broader HIV prevention strategies in Sub-Saharan Africa.
Why it matters
This finding could provide a cost-effective, dual-purpose public health intervention for regions struggling with multiple infectious diseases.
Researchers say elephantiasis elimination should be included in HIV prevention strategies.
The article summarizes scientific research findings and expert recommendations without bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in